ULBI
Ultralife Corporation
5.70$
+1.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +14.9% | +7.9% | +3.7% | +1.9% | +22.5% | +0.9% | -8.8% | +34.2% | +20.3% | +3.7% | +16.2% | |
| – | +12.7% | +8.0% | +3.4% | +3.9% | +22.8% | +3.9% | -6.3% | +39.1% | +16.6% | +2.3% | +20.1% | |
| – | +20.5% | +7.7% | +4.5% | -2.5% | +21.8% | -6.4% | -15.5% | +19.3% | +33.3% | +7.9% | +5.2% | |
| – | +5.1% | +6.1% | -20.3% | -4.8% | +51.0% | -12.6% | +14.8% | +3.7% | +6.4% | +9.8% | +8.9% | |
| – | -8.1% | +6.5% | -0.5% | -3.3% | +17.0% | +3.1% | +1.5% | +24.8% | +1.4% | +7.0% | +21.9% | |
| – | -4.6% | +7.6% | -7.4% | -3.7% | +25.1% | -1.4% | +4.9% | +19.0% | +1.6% | +8.8% | +9.1% | |
| – | – | +13.0% | +72.1% | +1.2% | +12.4% | -22.6% | -99.4% | +268.6% | +7,245.0% | +5.2% | -7.5% | |
| – | +13.8% | +6.0% | -30.4% | -65.6% | +755.6% | -19.1% | -44.5% | +293.0% | +112.0% | -3.8% | +103.8% | |
| – | – | +13.7% | +75.8% | +5.1% | +2.4% | +3.7% | -102.2% | – | – | -9.0% | -201.2% | |
| – | +15.7% | -68.4% | -1,496.9% | – | – | +16.1% | -95.3% | -512.7% | – | -3.0% | -229.3% | |
| – | – | +22.3% | +118.0% | +226.0% | -79.1% | +0.5% | -104.5% | – | – | -12.3% | -193.4% | |
| – | – | +6.1% | +37.2% | +0.2% | +12.7% | +3.4% | -65.1% | +36.7% | +203.1% | -4.3% | -92.7% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.